Deep search
Search
Images
Videos
Maps
News
Shopping
Copilot
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Merck, Eisai's combination drug fails in late-stage trial for esophageal cancer
Merck and Japan-based Eisai said on Friday a combination of their therapies failed to extend the lives of patients with a type of esophageal cancer in a late-stage trial. The trial was studying U.S. drugmaker Merck's blockbuster immunotherapy Keytruda and Eisai's Lenvima,
Merck and Eisai report mixed results in Phase 3 cancer trial
Co., Inc. (NYSE:MRK) and Eisai Co., Ltd. (TYO:4523) have announced the latest outcomes from their Phase 3 LEAP-015 trial, which evaluated the efficacy of the combination therapy KEYTRUDA and LENVIMA for patients with advanced gastroesophageal adenocarcinoma.
Merck, Eisai post mixed Phase 3 data for Keytruda/ Lenvima in GIT cancer
Merck (NYSE:MRK) and Esai (OTCPK:ESALF) (OTCPK:ESAIY) announced Friday a mixed outcome in their Phase 3 LEAP-015 trial, which was designed to evaluate MRK’s anti-PD-1 therapy Keytruda and the Japanese pharma giant’s tyrosine kinase inhibitor Lenvima for a certain type of cancer in the gastrointestinal tract.
Merck and Eisai's cancer drugs fail to improve overall survival in late-stage trial
Merck's blockbuster drug Keytruda and Eisai's cancer drug Lenvima, in combination with chemotherapy, failed to improve overall survival in patients with a type of esophageal cancer in a late-stage trial,
1h
on MSN
'All My Children' actor Colin Egglesfield says cancer returned, undergoes surgery
Colin Egglesfield, known for his work on "All My Children" and "Something Borrowed," revealed he had undergone surgery for ...
4h
They both lost their spouses to cancer. Then they unexpectedly found love on opposite sides of the world
Widow Catherine Robinson, from Australia, stumbled across American widower Randy Mann’s blog in 2018. The two strangers ...
2h
on MSN
‘Full House’ star’s wife says his cancer battle ‘getting more difficult’
“Full House” star Dave Coulier’s battle with cancer is getting tougher, according to his wife. It was announced in October ...
1d
A Start-Up Claimed Its Device Could Cure Cancer. Then Patients Began Dying.
Two U.S. companies teamed up to treat cancer patients using an unproven blood filter in Antigua, out of reach of American ...
6h
on MSN
Hotels, travel industry heed US surgeon general's alcohol-cancer warning
Following the U.S. surgeon general's new advisory linking alcohol to seven different types of cancer, hotels are expanding ...
2h
on MSN
Daytime soap star, ‘Melrose Place’ actor battling cancer for third time
Colin Egglesfield, best known for his roles in “All My Children” and “Melrose Place,” revealed he is battling cancer for a ...
2d
The ultra-fast cancer treatments which could replace conventional radiotherapy
A pioneering new treatment promises to tackle a wider range of cancers, with fewer side-effects than conventional ...
1d
A grim prognosis, a gamble and one patient’s fight to defy cancer
After a Stage 4 cancer diagnosis and a prognosis of 16 months to live, Katie Doble didn’t know whether she should plan her ...
2d
on MSN
Q&A: Cancer Death Rates Are Down But Inequalities Persist
The cancer mortality rate continued to decline but increases in cancer in young people, women and populations of color are ...
9h
New cancer care approach 'tip of iceberg' - doctor
Using the technology was the "tip of the iceberg" for the future of cancer care, Dr Al-Qaisieh added. Traditionally, patients ...
1d
on MSN
Trump's AI deal fueling early cancer detection: Oracle's Larry Ellison
Oracle founder Larry Ellison said the Stargate project, a joint venture with OpenAI and Softbank, will help to fuel the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback